Leading High-Quality Specialized Respiratory Disease Care
through the Integration of Biosensing and AI
through the Integration of Biosensing and AI
Ultra-Precision Sensing Technology
Breath Gas Test System
Model BA200
Designed for non-invasive point-of-care assessment of airway inflammation, this device combines high-sensitivity biosensor technology (0.1 ppb) with full ATS/ERS compliance. It delivers multi-parameter results—FeNO, CaNO, FnNO—in under one minute, while a patented dual-channel design ensures complete protection against cross-contamination.
MoreGlobal Presence
Who We Are
MISSION
Driven by a passion for innovation and a commitment to excellence, desire to maintain high levels of innovation, knowledge, technical expertise, service.
PRODUCT FOCUS
Committed to providing solutions for respiratory diseases, cardiovascular diseases and metabolic diseases
VISION
Become a global provider in comprehensive chronic disease solution for both professional segment and homecare.
News, Events and Highlights
FeNO50 vs. FeNO200: Two Windows into Airway Inflammation
When you exhale, your breath carries far more than carbon dioxide and water vapor. It also contains trace amounts of nitric oxide (NO), a gas produced by inflamed airway tissues. Measuring the concentration of NO in exhaled breath —...
Asthma: A Comprehensive Guide to the Chronic Airway Disease
What Is Asthma? Asthma is a chronic condition in which the airways in the lungs become inflamed and narrow, making it difficult to breathe. The disease is characterized by diffuse airway inflammation triggered by a variety of stimuli, res...
UBreath at ERS 2026: Interactive FeNO Challenge and Precision Respiratory Diagnostics Draw Strong Interest
Barcelona, Spain — September 2026 — UBreath® successfully concluded an active and productive week at the European Respiratory Society (ERS) Congress 2026, held September 5–9 at Fira Gran Via in Barcelona. At Booth R0...
Advancing Precision in Respiratory Care
Please complete the form to contact our team